Clinical impact from the foreign material, if present, is expected to be rare. No additional information about the „foreign substance” was provided. The voluntary recall includes a single lot of bottles, each containing 500 0.5-milligram tablets, that were distributed in the United States between July and August 2019. The number of the affected lot is 8082708 and the expiration date is listed as September 2020. Mylan has notified its distributors and customers about the recall by letter. Consumers must contact Stericycle at 1-888-843-0255 for the documentation packet to return product to Stericycle.
They should contact their physician or healthcare provider if they have experienced any problems that may be related to using this drug product. The recall announcement was posted on the FDA website too. Alprazolam Tablets are indicated for the management of anxiety disorder, the short-term relief of symptoms of anxiety, and the treatment of panic disorder, with or without agoraphobia. Mylan Pharmaceuticals Inc. is one of the world’s largest producers of active pharmaceutical ingredients.